Mauro Di Bari1, Daniela Balzi2, Stefania Fracchia1, Alessandro Barchielli2, Francesco Orso1, Andrea Sori3, Simona Spini4, Nazario Carrabba5, Giovanni M Santoro6, Gian Franco Gensini7, Niccolò Marchionni1. 1. Department of Experimental and Clinical Medicine, Research Unit of Medicine of Aging, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. 2. Epidemiology Unit, Local Health Unit 10, Florence, Italy. 3. Department of Cardiovascular Medicine, Unit of Internal Medicine and Cardiology, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. 4. Cardiology Unit, Santa Maria Nuova Hospital, Local Health Unit 10, Florence, Italy. 5. Department of Cardiovascular Medicine, Cardiology Unit 1, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. 6. Cardiology Unit, Nuovo San Giovanni di Dio Hospital, Local Health Unit 10, Florence, Italy. 7. Department of Experimental and Clinical Medicine, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Fondazione Don Carlo Gnocchi IRCCS, Florence Italy.
Abstract
BACKGROUND: Application of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) is suboptimal in older frail individuals. This study was conducted to verify if background risk is a risk factor for underuse and diminished effectiveness of PCI in older patients. METHODS: An observational cohort study was conducted using data from the Acute Myocardial Infarction in Florence 2 registry, including all ACS hospitalised in 1 year in the area of Florence, Italy. Patients aged 75+ years were selected, whose background risk was stratified with the Silver Code (SC), a validated tool predicting mortality based upon administrative data. Multivariable OR for PCI application and HR for 1-year mortality by PCI usage were calculated. RESULTS: In 698 patients (358 women, mean age 83 years), of whom 176 had ST-segment elevation myocardial infarction (STEMI), for each point increase in SC score the odds for application of PCI decreased by 11%, whereas the hazard of 1-year mortality increased by 10%, adjusting for positive and negative predictors. PCI reduced 1-year mortality progressively more with increasing SC, with HR (95% CI) of 0.8 (0.19 to 1.21), 0.41 (0.18 to 0.45), 0.41 (0.23 to 0.74) and 0.26 (0.14 to 0.48) for SC of 0-3, 4-6, 7-10 and 11+. CONCLUSIONS: Application of PCI in older ACS patients decreased with increasing background risk. This therapeutic attitude could not be justified by decreasing effectiveness of PCI in more compromised patients: conversely, application of PCI was associated with a long-term survival advantage that increased progressively with background risk, as expressed by SC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Application of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) is suboptimal in older frail individuals. This study was conducted to verify if background risk is a risk factor for underuse and diminished effectiveness of PCI in older patients. METHODS: An observational cohort study was conducted using data from the Acute Myocardial Infarction in Florence 2 registry, including all ACS hospitalised in 1 year in the area of Florence, Italy. Patients aged 75+ years were selected, whose background risk was stratified with the Silver Code (SC), a validated tool predicting mortality based upon administrative data. Multivariable OR for PCI application and HR for 1-year mortality by PCI usage were calculated. RESULTS: In 698 patients (358 women, mean age 83 years), of whom 176 had ST-segment elevation myocardial infarction (STEMI), for each point increase in SC score the odds for application of PCI decreased by 11%, whereas the hazard of 1-year mortality increased by 10%, adjusting for positive and negative predictors. PCI reduced 1-year mortality progressively more with increasing SC, with HR (95% CI) of 0.8 (0.19 to 1.21), 0.41 (0.18 to 0.45), 0.41 (0.23 to 0.74) and 0.26 (0.14 to 0.48) for SC of 0-3, 4-6, 7-10 and 11+. CONCLUSIONS: Application of PCI in older ACS patients decreased with increasing background risk. This therapeutic attitude could not be justified by decreasing effectiveness of PCI in more compromised patients: conversely, application of PCI was associated with a long-term survival advantage that increased progressively with background risk, as expressed by SC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
Coronary Artery Disease; Quality of Care and Outcomes
Authors: Gregory M Ouellet; Mary Geda; Terrence E Murphy; Sui Tsang; Mary E Tinetti; Sarwat I Chaudhry Journal: J Am Geriatr Soc Date: 2017-10-18 Impact factor: 5.562
Authors: Daniel I Bromage; Daniel A Jones; Krishnaraj S Rathod; Claire Grout; M Bilal Iqbal; Pitt Lim; Ajay Jain; Sundeep S Kalra; Tom Crake; Zoe Astroulakis; Mick Ozkor; Roby D Rakhit; Charles J Knight; Miles C Dalby; Iqbal S Malik; Anthony Mathur; Simon Redwood; Philip A MacCarthy; Andrew Wragg Journal: J Am Heart Assoc Date: 2016-06-27 Impact factor: 5.501